Topical Niosome Gel of Zingiber cassumunar Roxb. Extract for Anti-inflammatory Activity Enhanced Skin Permeation and Stability of Compound D

AAPS PharmSciTech

Volumn 17, Issue 3, 2016, Pages 631-639

  Priprem, Aroonsri ^a   Janpim, Khwanhatai ^a   Nualkaew, Somsak ^b   Mahakunakorn, Pramote ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b MAHASARAKHAM UNIVERSITY   (Thailand)

Author keywords

Activation energy; Compound D; Niosomal gel; Topical anti inflammatory; Zingiber cassumunar

Indexed keywords

4 (3',4' DIMETHOXYPHENYL)BUT 3 EN 1 OL; ANTIINFLAMMATORY AGENT; CROTON OIL; HYDROCORTISONE; NIOSOME; PIROXICAM; UNCLASSIFIED DRUG; 4-(3',4'-DIMETHOXYPHENYL)BUT-3-EN-1-OL; BUTANOL; GEL; LIPOSOME; NONSTEROID ANTIINFLAMMATORY AGENT; PLANT EXTRACT;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CREAM; DEGRADATION KINETICS; DRUG DECOMPOSITION; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG STRUCTURE; EAR EDEMA; ENCAPSULATION; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN PERMEABILITY; TAIL FLICK TEST; TEMPERATURE ACCLIMATIZATION; THERMOSTABILITY; ZINGIBER MONTANUM; ANIMAL; DRUG EFFECTS; EDEMA; GINGER; INSTITUTE FOR CANCER RESEARCH MOUSE; ISOLATION AND PURIFICATION; METABOLISM; NEWBORN; ORGAN CULTURE TECHNIQUE; PAIN MEASUREMENT; PHYSIOLOGY; PIG; PROCEDURES; RANDOMIZATION; SKIN ABSORPTION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANIMALS, NEWBORN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUTANOLS; DRUG STABILITY; EDEMA; GELS; GINGER; LIPOSOMES; MALE; MICE; MICE, INBRED ICR; ORGAN CULTURE TECHNIQUES; PAIN MEASUREMENT; PLANT EXTRACTS; RANDOM ALLOCATION; SKIN ABSORPTION; SWINE;

EID: 84939604140     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-015-0376-z     Document Type: Article

References (42)

1. Moghassemi S, Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release. 2014;185:22–36.
2. Mahale NB, Thakkar PD, Mali RG, Walung DR, Chaudhari SR. Niosomes: novel sustained release nonionic stable vesicle systems-an overview. Adv Colloid Interf Sci. 2012;183–184:46–54.
3. Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta Pharm Sin B. 2011;1(4):208–19.
4. Agrawal R, Sandhu SK, Sharma I, Kaur IP. Development and evaluation of curcumin-loaded elastic vesicle as an effective topical anti-inflammatory formulation. AAPS PharmSciTech. 2014. doi:10.1208/s12249-014-0232-6.
5. Muzzalupo R, Tavano L, Cassano R, Trombino S, Ferrarelli T, Picci N. A new approach for the evaluation of niosomes as effective transdermal drug delivery systems. Eu J Pharm Biopharm. 2011;79:28–35.
6. Junyaprasert VB, Singhsa P, Suksiriworapong J, Chantasart D. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid. Int J Pharm. 2013;423:303–11. doi:10.1016/j.ijpharm.2011.11.032.
7. Yeh MI, Huang HC, Liaw JH, Huang MC, Huang KF, Hsu FL. Dermal delivery by niosomes of black tea extract as sunscreen agent. Int J Dermatol. 2013;52:239–45.
8. Gupta NK, Dixit VK. Development and evaluation of vesicular system for curcumin delivery. Arch Dermatol Res. 2011;303:89–101. doi:10.1007/s00403-010-1096-0.
9. Peppas NA, Bures P, Leobandung W, Ichikawa H. Hydrogels in pharmaceutical formulations. Eu J Pharm Biopharm. 2000;50:27–46.
10. Alam MI, Baboota S, Kohli K, Ali J, Ahuja A. Pharmacodynamic evaluation of niosomal transdermal therapeutic gel containing celecoxib. Sci Asia. 2010;36:305–11.
11. Kumbhar D, Wavikar P, Vavia P. Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamics activity. AAPS Pharma Sci Tech. 2013;14(3):1072–82. doi:10.1208/s12249-013-9986-5.
12. Shahiwala A, Misra A. Studies in topical application of niosomally entrapped nimesulide. J Pharm Pharm Sci. 2002;5(3):220–5.
13. Gupta A, Singh S, Kotia NG, Webster TJ. Formulation and evaluation of a topical niosomal gel containing a combination of benzoyl peroxide and tretinoin for antiacne activity. Int J Nanomedicine. 2015;10:171–82.
14. Tuntiwachwuttikul P. Phenylbutanoids from Zingiber cassumunar. Phytochemistry. 1981;20(5):1164–5.
15. Ozaki Y, Kawahara N, Harada M. Anti-inflammatory effect of Zingiber cassumunar Roxb. and its active principles. Chem Pharm Bull. 1991;39(9):2353–6.
16. Masuda T, Jitoe A. Phenylbutenoid monomers from the rhizomes of Z. cassumunar. Phytochemistry. 1995;39(2):459–61.
17. Pongprayoon U, Soontornsaratune P, Jarikasem S, Sematong T, Wasuwat S, Claeson P. Topical anti-inflammatory activity of the major lipophilic constituents of the rhizome of Zingiber cassumunar. Part I: the essential oil. Phytomedicine. 1996;3(4):319–22.
18. Pongprayoon U, Tuchinda P, Claeson P, Sematong T, Reutrakul V, Soontornsaratune P. Topical anti-inflammatory activity of the major lipophilic constituents of the rhizome of Zingiber cassumunar. Part II: Hexane extractives. Phytomedicine. 1997;3:323–6.
19. Panthong A, Kanjanapothi D, Niwatananant W, Tuntiwachwuttikul P, Reutrakul V. Anti-inflammatory activity of compound D {(E)-4-(3’,4’-dimethoxyphenyl)but-3-en-2-ol} isolated from Zingiber cassumunar Roxb. Phytomedicine. 1997;4(3):207–12.
20. Suksaeree J, Charoenchai L, Madaka F, Monton C, Sakunpak A, Charoonratana T, Pichayakorn W. Zingiber cassumunar blended patches for skin application: formulation, physicochemical properties, and in vitro studies. Asian J Pharm Sci. 2015. (in press) http://dx.doi.org/10.1016.j.ajps.2015.03.001.
21. Manochai B, Paisooksantivatana Y, Choi H, Hong JH. Variation in DPPH scavenging activity and major volatile oil components of cassumunar ginger, Zingiber montanum (Koenig), in response to water deficit and light intensity. Sci Hortic. 2010;126:462–6.
22. Kladmook M, Chidchenchey S, Keeratinijakal V. Assessment of genetic diversity in cassumunar ginger (Zingiber cassumunar Roxb.) in Thailand using AFLP markers. Breed Sci. 2010;60:412–8.
23. Chaiwongsa R, Ongchai S, Tangyuenyon S, Kontawelert P, Panthong A, Reutrakul V. Chondroprotective potential of bioactive compounds of Zingiber cassumunar Roxb. against cytokine-induced cartilage degradation in explants tissue. J Med Plants Res. 2012;6(39):5204–13.
24. Chaiwongsa R, Ongchai S, Boonsing P, Kongtawelert P, Panthong A, Reutrakul V. Active compound of Zingiber cassumunar Roxb. down-regulates the expression of genes involved in joint erosion in a human synovial fibroblast cell line. Afr J Tradit Complement. 2012;10(1):40–8.
25. Han AR, Jeong YH, Lee SK, Seo EK. Cyclooxygenase-2 inhibitory phenylbutenoids from the rhizomes of Zingiber cassumunar. Chem Pharm Bull. 2005;53(11):1466–8.
26. Waltenberger B, Schuster D, Paramapojn S, Gritsanapan W, Wolber G, Rollinger JM, et al. Predicting cyclooxygenase inhibition by three-dimensional pharmacophoric profiling. Part II: Identification of enzyme inhibitors from Prasaplai, a Thai traditional medicine. Phytomedicine. 2011;18:119–33. doi:10.1016/j.phymed.2010.08.002.
27. Sukatta U, Rugthaworn P, Punjee P, Chidchenchey S, Keeratinijakal V. Chemical composition and physical properties of oil from ZC (Zingiber cassumunar Roxb.) obtained by hydro distillation and hexane extraction. Kasetsart J (Nat Sci). 2009;43:212–7.
28. Pithayanukul P, Tubprasert J, Wuthiudomlert M. In vitro antimicrobial activity of Zingiber cassumunar (Plai) oil and 0.5% Plai oil gel. Phytother Res. 2007;2(2):164–9.
29. Sunintaboon P, Pumduang K, Vongsetskul T, Pittayanuruk P, Anantachoke N, Tuchinda P. One-step preparation of chitosan/sodium dodecyl sulfate-stabilized-oil-in-water emulsion of Zingiber cussumunar Roxb. oil extracts. Colloid Surf A. 2012;414:151–9.
30. Kaewchoothong A, Tewtrakul S, Panichayupakaranant P. Inhibitory effect of phenylbutanoid-rich Zingiber cassumunar extracts on nitric oxide production by murine macrophage-like RAW264.7 cells. Phytother Res. 2012;26:1789–2.
31. Suksaeree J, Charoenchai L, Pichayakorn W, Boonme P. HPLC method development and validation of (E)-4-(3,4-dimethoxyphenyl)-but-3-en-1-ol in Zingiber cassumunar Roxb. from Thai Herbal Compress ball. Int J Pharm Pharm Sci Res. 2013;3(3):115–7.
32. Mandal S, Banerjee C, Ghosh S, Kuchlyan J, Sarkar N. Modulation of the photophysical properties of curcumin in nonionic surfactant (Tween 20) forming micelles and niosomes: a comparative study of different microenvironments. J Phys Chem B. 2013;117:6957–68.
33. Cilurzo F, Minghetti P, Sinico C. Newborn pig skin as model membrane in in vitro drug permeation studies: a technical note. AAPS Pharm Sci Tech. 2007;8(4) article 94.
34. Sekkat N, Kalia YN, Guy RH. Porcine ear skin as a model for the assessment of transdermal delivery to premature neonates. Pharm Res. 2004;21(8):1390–7.
35. Committee for the Update of the Guide of the Care and Use of Laboratory Animals (US); National Research Council of the National Academies (US). Guide for the care and use of laboratory animals. 8th ed. Washington DC: National Academies Press; 2011.
36. Tubaro A, Dri P, Melato M, Mulas G, Bianchi P, Negro PD, et al. In the croton oil ear test the effects of non-steroidal anti-inflammatory drugs (NSAIDS) are dependent on the dose of the irritant. Agents Actions. 1986;19(5/6):371–73.
37. Chooluck K, Singh R, Sathirakul K, Derendorf H. Dermal pharmacokinetics of terpinen-4-ol following topical administration of Zingiber cassumunar (plai) oil. Planta Med 2012. DOI http://dx.doi.org/10.1055/s-0032-1315262.
38. Lardner A. The effect of extracellular pH on immune function. J Leukoc Biol. 2001;69:522–30.
39. Steen KH, Steen AE, Reeh PW. A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin, in vitro. J Neurosci. 1995;15(5):3982–9.
40. Young JM, Wagner BM, Spires DA. Tachyphylaxis in 12-o-tetradecanoylphobol acetate- and arachidonic acid-induced ear edema. J Invest Dermatol. 1983;80:48–52.
41. Rogerson A, Cummings J, Florence AT. Adriamycin-loaded niosomes: drug entrapment, stability and release. J Microencapsul. 1987;4(4):321–8. doi:10.3109/02652048709021824.
42. Rungpanichkul N, Nimmannit U, Muangsiri W, Rojsitthisak P. Preparation of curcuminoid niosomes for enhancement of skin permeation. Pharmazie. 2011;66570–575. doi: 10.1691/ph.2011.1018.